Bayer Asia Posts Rapid Growth As Cancer and AMD Products Gain
This article was originally published in PharmAsia News
Executive Summary
Bayer HealthCare in Asia was the fastest growing division of the parent company’s pharmaceutical business, with cancer drugs and wet AMD treatment Eylea leading to a banner year in the region.